AlphaMaven AlphaMaven

Stablecoins, AI-biotech could drive next VC wave: Insignia Ventures Partners

Reported by Cnbc
Jul 7, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Insignia Ventures Partners identifies stablecoins, agentic payments, and AI-biotech integration as the next wave of venture capital investment opportunities following the artificial intelligence cycle.
  • • Vietnam and Malaysia are emerging as key startup hubs in Southeast Asia alongside established markets Singapore and Indonesia, signaling geographic diversification of VC deployment in the region.
  • • Stablecoins and payments infrastructure represent a distinct investment thesis distinct from the preceding AI-focused venture cycle, suggesting capital rotation toward cryptocurrency and fintech applications.
  • • AI's intersection with biotech represents a convergence play that Insignia expects to attract meaningful venture funding in the near term.
Summary
Yinglan Tan of Insignia Ventures Partners outlined an anticipated shift in Southeast Asian venture capital allocation, identifying three primary investment vectors poised to attract institutional capital following the artificial intelligence boom. According to Tan's assessment, stablecoins—which address payment settlement and currency stability concerns—agentic payments systems, and the integration of AI with biotechnology represent the most promising deployment opportunities for the next venture wave.

Geographically, Insignia's analysis signals capital expansion beyond Singapore and Indonesia, traditionally the region's dominant startup ecosystems. Vietnam and Malaysia are positioned as emerging hubs with increasing relevance to institutional allocators seeking exposure to Southeast Asian growth dynamics. This geographic broadening reflects both market maturation and the dispersion of technological talent and entrepreneurial activity across the region.

The analyst's framing suggests a structured thesis transition: whereas venture deployment over the preceding period concentrated heavily on artificial intelligence applications and infrastructure, upcoming allocation will bifurcate toward payments and financial infrastructure (stablecoins and agentic payments) and specialized biotech applications enhanced by machine learning. This divergence implies differentiated risk-return profiles and sector-specific due diligence requirements for institutional investors monitoring Southeast Asian venture trends.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Cnbc Stablecoins, AI-biotech could drive next VC wave: Insignia Ventures Partners